The Impact of Tumor Hypoxia Modulation on sIL-2R Levels in Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL) Patients Undergoing Chemotherapy: A Randomized Clinical Trial.

Daniel RizkyKevin TandartoEko Adhi PangarsaRidho M NaibahoSigit P KurniawanDamai SantosaBudi SetiawanCatharina Suharti

Published in: Asian Pacific journal of cancer prevention : APJCP (2024)

Tumor hypoxia modulation led to a significant decrease in serum sIL-2R levels, potentially through improvements in the crosstalk between hypoxia and inflammation pathways.

Keyphrases

diffuse large b cell lymphoma
newly diagnosed
patients undergoing
epstein barr virus
endothelial cells
oxidative stress
locally advanced